Occurrence and significance of epithelial-mesenchymal transition in breast cancer

被引:36
|
作者
Roxanis, Ioannis [1 ]
机构
[1] Oxford Univ Hosp, Dept Cellular Pathol, Oxford OX3 9DU, England
关键词
RECEPTOR TYROSINE KINASES; E-CADHERIN EXPRESSION; ACTIVATED AKT KINASE; GROWTH-FACTOR-BETA; TGF-BETA; TUMOR PROGRESSION; BASAL-LIKE; DUCTAL CARCINOMA; COLORECTAL CANCERS; SIGNALING PATHWAYS;
D O I
10.1136/jclinpath-2012-201348
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
By contrast with developmental epithelial-mesenchymal transition (EMT), where epithelial characteristics undergo transformation to a mesenchymal-like phenotype in a coordinated fashion, oncogenic EMT occurs in the context of unpredictable genetic changes present in the tumour cells, as well as an abnormal tumour microenvironment. Therefore, a partial form of EMT has been proposed as variably participating in the establishment of invasive phenotype in different types of breast carcinoma, in keeping with their morphological and phenotypical diversity. A complex network of signalling pathways and transcription factors appears responding to various growth factors and cytokines released by stromal and neoplastic elements, endowing the system with abundant regulatory opportunities. The process of EMT is largely elusive in histopathological preparations, prompting doubts regarding its significance in tumour progression. This might be related to the presumed focal occurrence of EMT in the majority of tumours. Detailed topological studies might facilitate understanding of the orchestration of events taking place in vivo. Even more importantly, clinical correlations can be endeavoured and, in parallel with advancement in molecular pathology, a contribution to taxonomy refinement can be envisaged.
引用
收藏
页码:517 / 521
页数:5
相关论文
共 50 条
  • [31] Epithelial-mesenchymal transition in gastric cancer
    Gurzu, Simona
    Fetyko, Anna Maria
    Bara, Tivadar
    Bars, Tivadar, Jr.
    Jung, Ioan
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S6 - S6
  • [32] Lung cancer and epithelial-mesenchymal transition
    Toshi Menju
    Hiroshi Date
    General Thoracic and Cardiovascular Surgery, 2021, 69 : 781 - 789
  • [33] Epithelial-mesenchymal transition in gastric cancer
    Huang, Lei
    Wu, Ruo-Lin
    Xu, A-Man
    AMERICAN JOURNAL OF TRANSLATIONAL RESEARCH, 2015, 7 (11): : 2141 - 2158
  • [34] Epithelial-mesenchymal transition and cancer.
    Arvelo, Francisco
    Sojo, Felipe
    INVESTIGACION CLINICA, 2023, 64 (03): : 379 - 404
  • [35] Lung cancer and epithelial-mesenchymal transition
    Menju, Toshi
    Date, Hiroshi
    GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 2021, 69 (05) : 781 - 789
  • [36] Epithelial-mesenchymal transition in development and cancer
    Micalizzi, Douglas S.
    Ford, Heide L.
    FUTURE ONCOLOGY, 2009, 5 (08) : 1129 - 1143
  • [37] Abnormalities in miRNAome contribute to epithelial-mesenchymal transition of breast cancer cells
    Halytskiy, V.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S24 - S24
  • [38] SMYD3 promotes the epithelial-mesenchymal transition in breast cancer
    Fenizia, Claudio
    Bottino, Cinzia
    Corbetta, Silvia
    Fittipaldi, Raffaella
    Floris, Pamela
    Gaudenzi, Germano
    Carra, Silvia
    Cotelli, Franco
    Vitale, Giovanni
    Caretti, Giuseppina
    NUCLEIC ACIDS RESEARCH, 2019, 47 (03) : 1278 - 1293
  • [39] TES was epigenetically silenced and suppressed the epithelial-mesenchymal transition in breast cancer
    Yang Yongbin
    Li Jinghua
    Zhao Zhanxue
    Zang Aimin
    Jia Youchao
    Shang Yanhong
    Jiao Manjing
    TUMOR BIOLOGY, 2014, 35 (11) : 11381 - 11389
  • [40] Bromodomain and extraterminal proteins regulate the epithelial-mesenchymal transition in breast cancer
    Andrieu, Guillaume
    Denis, Gerald V.
    CANCER RESEARCH, 2017, 77